Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)
对于高危（“难看”）局部晚期直肠癌，在放化疗前进行新辅助 FOLFOXIRI 方案：单臂、多中心、开放标签 II 期试验的研究方案 (MEND-IT)
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-022-09947-w
van den Berg, K; Schaap, D P; Voogt, E L K; Buffart, T E; Verheul, H M W; de Groot, J W B; Verhoef, C; Melenhorst, J; Roodhart, J M L; de Wilt, J H W; van Westreenen, H L; Aalbers, A G J; van 't Veer, M; Marijnen, C A M; Vincent, J; Simkens, L H J; Peters, N A J B; Berbée, M; Werter, I M; Snaebjornsson, P; Peulen, H M U; van Lijnschoten, I G; Roef, M J; Nieuwenhuijzen, G A P; Bloemen, J G; Willems, J M W E; Creemers, G J M; Nederend, J; Rutten, H J T; Burger, J W A
